Invesco Dynamic Biotechnology & Genome ETF (PBE) ETF

Expense Ratio: 0.57% | AUM: 241.57M | Issuer: Invesco

PBE Daily Price Range
PBE 52-Week Price Range

PBE - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

PBE has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

PBE - Profile & Info


The investment objective of the Invesco Dynamic Biotech & Genome ETF is based on the Dynamic Biotech & Genome Intellidex. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

Issuer Invesco
Expense Ratio 0.57%
Assets Under Management (AUM) 241.57M
Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $58.92
Options? Yes
Total Holdings 33

PBE - Top Holdings

Symbol Holding Name % of Total
REGN Regeneron Pharmaceuticals Inc 5.20%
AMGN Amgen Inc 5.08%
SRPT Sarepta Therapeutics Inc 5.06%
VRTX Vertex Pharmaceuticals Inc 5.05%
TECH BIOTECHNE CORP 4.93%
GILD GILEAD SCI 4.93%
NBIX Neurocrine Biosciences Inc 4.90%
BIIB BIOGEN INC 4.30%
OPK OPKO Health Inc 4.17%
DRNA DICERNA PHARMA 3.20%
CGEN Compugen Ltd 3.19%
AKBA Akebia Therapeutics Inc 3.10%
CRSP CRISPR Therapeutics AG 3.10%
HALO Halozyme Therapeutics Inc 3.01%
CDNA CareDx Inc 2.95%
IRWD Ironwood Pharmac 2.78%
UTHR United Therapeutics Corp 2.77%
XNCR Xencor Inc 2.75%
NKTR NEKTAR THERAP 2.74%
VNDA Vanda Pharmaceuticals Inc 2.72%
CHRS Coherus BioSciences Inc 2.58%
VCEL Vericel Corp 2.56%
MYOK MyoKardia Inc 2.54%
EBS EMERGENT BIOSO 2.54%
XLRN ACCELERON PHARMA INC 2.53%
IMGN IMMUNOGEN INC 2.52%
RGEN Repligen Corp 2.52%
CSII Cardiovascular Systems Inc 2.11%
MYGN Myriad Genetics Inc 2.07%
COLL Collegium Pharmaceutical Inc 1.99%
IUGXX Premier US Government Money Portfolio 0.12%
PBE Invesco Dynamic Biotech &Genome ETF 0.00%
-CASH- Cash/Receivables/Payables 0.00%

PBE - Top Stories


View All PBE News

PBE - Price/Volume Stats

Current price $59.49
Prev. close $58.85
Day low $59.00
Day high $60.09
52-week high $60.09
52-week low $38.08
Day Volume 13,521
Avg. volume 11,817
Dividend yield 0.05%

PBE - Recent Returns

1-mo 3.70%
3-mo 31.69%
6-mo 7.41%
1-year 9.64%
3-year 29.42%
5-year 5.20%
YTD 6.59%
2019 18.65%
2018 -0.19%
2017 22.28%
2016 -22.90%
2015 1.72%

PBE - Stock Chart


PBE - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular Articles



Page generated in 1.5402 seconds.